Evidence map›Paper›PMID 36240259›Full record

ArticlePLoS pathogens2022

Genetic diversity and evolutionary convergence of cryptic SARS- CoV-2 lineages detected via wastewater sequencing.

Devon A Gregory, Monica Trujillo, Clayton Rushford, Anna Flury, Sherin Kannoly, Kaung Myat San, Dustin T Lyfoung, Roger W Wiseman, Karen Bromert, Ming-Yi Zhou and 10 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed.

  1. Monoclonal antibodies from COVID-19 convalescent patients target cryptic epitopes for broad SARS-CoV-2 neutralization.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Real-time, multi-pathogen wastewater genomic surveillance with Freyja 2.medRxiv : the preprint server for health sciences · 2025
    Article
  11. Article
  12. Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Translating insights into therapies for Long Covid.Science translational medicine · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Devon A GregoryDepartment of Molecular Microbiology and Immunology, University of Missouri-School of Medicine, Columbia, Missouri, United States of America.
Monica TrujilloDepartment of Biological Sciences and Geology, Queensborough Community College of The City University of New York, New York City, New York, United States of America.
Clayton RushfordDepartment of Molecular Microbiology and Immunology, University of Missouri-School of Medicine, Columbia, Missouri, United States of America.
Anna FluryBiology Doctoral Program, The Graduate Center of The City University of New York, New York City, New York, United States of America.
Sherin KannolyBiology Department, Queens College of The City University of New York, New York City, New York, United States of America.
Kaung Myat SanBiology Department, Queens College of The City University of New York, New York City, New York, United States of America.
Dustin T LyfoungDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Roger W WisemanDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Karen BromertGenomics Technology Core, University of Missouri, Columbia, Missouri, United States of America.
Ming-Yi ZhouGenomics Technology Core, University of Missouri, Columbia, Missouri, United States of America.
Ellen KeslerGenomics Technology Core, University of Missouri, Columbia, Missouri, United States of America.
Nathan J BivensGenomics Technology Core, University of Missouri, Columbia, Missouri, United States of America.
Jay HoskinsEnvironmental Compliance Division, Engineering Department, Metropolitan St. Louis Sewer District, St. Louis, Missouri, United States of America.
Chung-Ho LinCenter of Agroforestry, School of Natural Resources, University of Missouri, Columbia, Missouri, United States of America.
David H O'ConnorDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Chris WiebergWater Protection Program, Missouri Department of Natural Resources, Jefferson City, Missouri, United States of America.
Jeff WenzelBureau of Environmental Epidemiology, Division of Community and Public Health, Missouri Department of Health and Senior Services, Jefferson City, Missouri, United States of America.
Rose S KantorDepartment of Civil and Environmental Engineering, University of California, Berkeley, California, United States of America.
John J DennehyBiology Doctoral Program, The Graduate Center of The City University of New York, New York City, New York, United States of America.
Marc C JohnsonDepartment of Molecular Microbiology and Immunology, University of Missouri-School of Medicine, Columbia, Missouri, United States of America.ORCID 0000-0002-6431-7133

Funding

Wastewater Detection of COVID-19U01DA053893 · NIDA · MISSOURI STATE DEPT/ HEALTH & SENIOR SRV · PI WENZEL, JEFF · 2021 to 2022
$4.0M
NIDA NIH HHS U01 DA053893
6 · The paper itself

Abstract

Wastewater-based epidemiology (WBE) is an effective way of tracking the appearance and spread of SARS-COV-2 lineages through communities. Beginning in early 2021, we implemented a targeted approach to amplify and sequence the receptor binding domain (RBD) of SARS-COV-2 to characterize viral lineages present in sewersheds. Over the course of 2021, we reproducibly detected multiple SARS-COV-2 RBD lineages that have never been observed in patient samples in 9 sewersheds located in 3 states in the USA. These cryptic lineages contained between 4 to 24 amino acid substitutions in the RBD and were observed intermittently in the sewersheds in which they were found for as long as 14 months. Many of the amino acid substitutions in these lineages occurred at residues also mutated in the Omicron variant of concern (VOC), often with the same substitutions. One of the sewersheds contained a lineage that appeared to be derived from the Alpha VOC, but the majority of the lineages appeared to be derived from pre-VOC SARS-COV-2 lineages. Specifically, several of the cryptic lineages from New York City appeared to be derived from a common ancestor that most likely diverged in early 2020. While the source of these cryptic lineages has not been resolved, it seems increasingly likely that they were derived from long-term patient infections or animal reservoirs. Our findings demonstrate that SARS-COV-2 genetic diversity is greater than what is commonly observed through routine SARS-CoV-2 surveillance. Wastewater sampling may more fully capture SARS-CoV-2 genetic diversity than patient sampling and could reveal new VOCs before they emerge in the wider human population.

Indexed as

COVID-19SARS-CoV-2AnimalsGenetic VariationHumansWastewaterWastewater

Identifiers

PMID36240259
PMCPMC9604950

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.